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http:WHAT THIS PAPER ADDS
The efﬁcacy of angiosome-targeted revascularization to achieve healing of ischemic tissue lesions of the foot and
limb salvage is controversial. The results of this meta-analysis suggest that, when feasible, direct revasculari-
zation of the foot angiosome affected may improve wound healing and limb salvage rates compared with in-
direct revascularization.Objective: The efﬁcacy of angiosome-targeted revascularization to achieve healing of ischemic tissue lesions of
the foot and limb salvage is controversial. This issue has been investigated in this meta-analysis.
Methods: A systematic review of the literature and meta-analysis of data on angiosome-targeted lower limb
revascularization for ischemic tissue lesions of the foot were performed.
Results: Nine studies reported on data of interest. No randomized controlled study was available. There were 715
legs treated by direct revascularization according to the angiosome principle and 575 legs treated by indirect
revascularization. The prevalence of diabetes was >70% in each study group and three studies included only
patients with diabetes. The risk of unhealed wound was signiﬁcantly lower after direct revascularization (HR 0.64,
95% CI: 0.52e0.8, I2 0%, four studies included) compared with indirect revascularization. Direct revascularization
was also associated with signiﬁcantly lower risk of major amputation (HR 0.44, 95% CI: 0.26e0.75, I2 62%, eight
studies included). Pooled limb salvage rates after direct and indirect revascularization were at 1 year 86.2% vs.
77.8% and at 2 years 84.9% vs. 70.1%, respectively. The analysis of three studies reporting only on patients with
diabetes conﬁrmed the beneﬁt of direct revascularization in terms of limb salvage (HR 0.48, 95% CI: 0.31e0.75,
I2 0%).
Conclusions: The results of the present meta-analysis suggest that, when feasible, direct revascularization of the
foot angiosome affected by ischemic tissue lesions may improve wound healing and limb salvage rates compared
with indirect revascularization. Further studies of better quality and adjusted for differences between the study
groups are needed to conﬁrm the present ﬁndings.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Ischemic tissue lesions of the foot carry an excessive risk of
major amputation, particularly in patients with diabetes.1
Prompt referral of these patients to a vascular surgeon for
assessment of lower limb circulation, revascularization, and
surgical wound care may avoid limb loss.2 A number of
patients with infected wounds or gangrene of the foot still
require major amputation despite an patent bypass graft or
a successful angioplasty. Such failures to achieve limb
salvage are often caused by aggressive infection or exten-
sive gangrene of the ischemic foot. However, recent studiesBiancari, Division of Cardio-thoracic and Vascular Surgery, Depart-
f Surgery, Oulu University Hospital, P.O. Box 21, 90029 Oulu, Finland.
il address: faustobiancari@yahoo.it (F. Biancari).
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//dx.doi.org/10.1016/j.ejvs.2013.12.010have suggested that the clinical success of bypass surgery or
angioplasty may depend on the target of revascularization.3
Two decades ago, Taylor and Palmer4 recognized the clinical
importance of angiosomes as three-dimensional units of
tissues fed by a source artery. They deﬁned six angiosomes
of the foot and ankle originating from the posterior tibial
artery (three angiosomes: the medial calcaneal artery
angiosome, the medial plantar artery angiosome, and the
lateral plantar artery angiosome), the anterior tibial artery
(one angiosome: the anterior tibial artery and dorsalis pedis
angiosome) and the peroneal artery (two angiosomes: the
lateral calcaneal artery angiosome and anterior perforator
artery angiosome). These angiosome units are bordered by
choke vessels, which link neighbouring angiosomes to each
other and demarcate the border of each angiosome.5
Furthermore, direct arterialearterial connections exist be-
tween angiosomes and compensate for ischemic events
occurring in an adjacent angiosome. As compensatory
518 F. Biancari and T. Juvonencollateral circulation can be affected by severe atheroscle-
rosis of the foot arteries,6 angiosome-targeted revasculari-
zation is expected to improve wound healing and limb
salvage compared with indirect revascularization, which
provides blood ﬂow only through collateral vessels origi-
nating from a non-affected angiosome. In other words,
direct revascularization of an artery feeding an area of the
foot, the angiosome, affected by ischemic wound or
gangrene is expected to have better chances of clinical
success than revascularization of any other artery not
directly feeding the affected anatomical area. However the
results of angiosome-targeted revascularization are
controversial.6e10 In the present meta-analysis, the poten-
tial beneﬁts of direct revascularization of ischemic tissue
lesions of the foot has been investigated.
METHODS
A literature review was performed through PubMed, Sco-
pus, Science Direct, and Google up to August 2013 for any
study evaluating the outcome of lower limb revasculariza-
tion according to the angiosome concept. Revascularization
of an artery in line with the angiosome affected by a foot
ischemic tissue lesion was deﬁned as direct revasculariza-
tion. The words employed in the search were: “angiosome”,
“limb”, and “foot”. Reference lists of obtained articles were
also searched.Inclusion criteria
Prospective and retrospective observational studies pub-
lished in English, Spanish, or Italian reporting on the
outcome of patients undergoing revascularization of the
lower limb following (direct revascularization) or not (in-
direct revascularization) the angiosome principle were
considered for this study. No date limit was set. Only
studies reporting on comparative analysis of any surgical,
endovascular, or hybrid direct versus indirect revascular-
ization were considered for inclusion in the present
analysis. As patients with critical limb ischemia are
exposed to a high risk of random censoring mostly
because of early and late mortality after revascularization,
only studies reporting on actuarial data were included in
this analysis.Exclusion criteria
Data reported only in abstracts were not included in this
analysis. Studies not reporting at least 6-month results were
not included in this study. Data on mean or median time-to-
event were not summarized because relevant times are
only known for the subset of patients who had the event or
were cured. This implies that censored patients must be
excluded as otherwise this may be a source of bias.Data collection and assessment of data quality
Articles potentially dealing with this topic were identiﬁed,
data were abstracted independently by both investigators
from all eligible studies using a standardized Excel ﬁle, dataon study design, study size, patient demographics, types of
intervention, and outcome were retrieved. Data were
retrieved only from the articles and no attempt was made to
get missing data from the authors. As only retrospective,
observational studies were expected to be included in this
analysis, the assessment of data quality was limited to veri-
fying whether the study groups were adjusted for baseline
variables or matched for any baseline variables or propensity
score. The guidelines for Meta-analysis of Observational
Studies in Epidemiology (MOOSE)11 were applied.
Outcomes of interest
The main outcome end-points of this study were wound
healing and limb salvage, which is freedom from major
lower limb amputation. Secondary outcome end-points
were survival and amputation-free survival.
Statistical analysis
Statistical analysis was performed using Review Manager
5.2 software (Version 5.2, The Nordic Cochrane Centre,
Copenhagen, Denmark) and Open Meta-analyst (http://
www.cebm.brown.edu/open_meta). The hazard ratios and
standard errors were calculated from actuarial curves or
data of individual studies using a graphical approach that
showed time trends.12 The natural logarithm of hazard ratio
and its standard error of direct versus indirect revasculari-
zation were entered into Review Manager to estimate
hazard ratios by generic inverse variance analysis. The
pooled risk of adverse event was expressed as hazard ratio
(HR) with 95% conﬁdence interval (95% CI). Because het-
erogeneity was anticipated in these observational studies,
this was taken into account a priori by using random effects
models (DerSimonianeLaird). Heterogeneity across studies
was evaluated using the I2 test, assuming that <40% in-
dicates a non-signiﬁcant heterogeneity. This proportion
meta-analysis was performed by estimating the ratio of the
number of events and the number of legs at risk at 1- and 2-
year intervals. Intermediate pooled overall leg salvage rates
were estimated and plotted at 1- and 2-year study intervals,
and hazard ratio was calculated using the graphical
approach by Tierney et al.12 A p value <0.05 was consid-
ered statistically signiﬁcant.
RESULTS
A literature search was performed on August 19, 2013 and
yielded 45 articles, of which nine6e8,13e18 were found to
report data of interest and fulﬁlled the inclusion criteria of
the present study (Fig. 1). No randomized controlled study
was available for this analysis.
Table 1 summarizes the main characteristics of these
studies. These studies included 715 legs treated by direct
revascularization and 575 legs treated by indirect revas-
cularization. The studies reported a prevalence of diabetes
>70% in each study group, and three studies13,15,18
included only patients with diabetes. Only three
studies8,14,15 reported on propensity score matched
analysis. Otherwise, none of these studies reported data
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Potentially relevant studies identified 
and screened for retrieval
n = 45
Potentially appropriate studies to be 
included in the meta-analysis 
n = 13
Studies included in this meta-analysis
n = 9
Not pertinent studies n = 9
Studies retrieved for more detailed 
evaluation 
n = 36
Studies excluded = 23
Review = 14
Editorial/Letter = 3
Duplicate = 2
Case report = 3
Other specified language= 1
Studies excluded n = 4
No actuarial data = 4
Figure 1. Literature search ﬂow-chart.
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groups.
Analysis of data from four studies reporting the wound
healing rate6,8,15,16 showed that the risk of unhealed wound
was signiﬁcantly lower after direct revascularization (HR
0.64, 95% CI: 0.52e0.8, I2 0%, Figs. 2 and 3). Analysis of two
studies8,15 reporting data on propensity score matched
analysis showed a trend toward a better wound healing rate
after direct revascularization (HR 0.72, 95% CI: 0.50e1.04, I2
29%). Analysis of data from eight studies reporting on limb
salvage rates6,7,13e18 showed that direct revascularization
was associated with a signiﬁcantly lower risk of major
amputation compared with indirect revascularization (HR
0.44, 95% CI: 0.26e0.75, I2 62%, Figs. 4 and 5). The analysis
of three studies reporting only on diabetic patients13,15,18
conﬁrmed the beneﬁt of direct revascularization in terms
of limb salvage (HR 0.48, 95% CI: 0.31e0.75, I2 0%).
Exclusion of two studies with outlier HR (lnHR < 1.0)17,18
conﬁrmed the efﬁcacy of direct revascularization in
achieving limb salvage (HR 0.64, 95% CI 0.46e0.88, I2 0%).
Kabra et al.16 included one patient with Rutherford class 4
in the direct revascularization group. When this study was
excluded from the analyses, direct revascularization was still
associated with signiﬁcantly better wound healing (HR 0.65,
95% CI 0.53e0.80, I2 0%) and limb salvage (HR 0.43, 95% CI
0.24e0.77, I2 67%).
Fig. 6 summarizes the 2-year limb salvage rates after
direct and indirect revascularization for ischemic tissue le-
sions of the foot. Pooled limb salvage rates after direct and
indirect revascularization were 86.2% vs. 77.8% at 1 year
and 84.9% vs. 70.1% at 2 years (six studies
included).6,7,13,14,18
Only two studies14,15 reported on amputation-free sur-
vival, showing only a trend in favour of direct revasculari-
zation over indirect revascularization (HR 0.81, 95% CI:
0.61e1.06, I2 0%). Two studies15,18 reported on similar
survival in these two study groups (HR 0.79, 95% CI: 0.47e
1.35, I2 25%).
Figure 2. Forest plot for effectiveness of direct revascularization versus indirect revascularization according to the angiosome concept in
wound healing in patients with ischemic tissue lesions of the foot.
Figure 3. Funnel plot for effectiveness of direct revascularization
versus indirect revascularization according to the angiosome
concept in wound healing in patients with ischemic tissue lesions
of the foot.
520 F. Biancari and T. JuvonenDISCUSSION
The present meta-analysis showed that direct revasculari-
zation of an artery feeding a foot angiosome affected by an
ischemic tissue lesion may signiﬁcantly improve the wound
healing and limb salvage rates compared with indirect
revascularization. These ﬁndings are of clinical relevance
particularly because the signiﬁcantly improved outcome
after direct revascularization should be viewed in the light
of current satisfactory limb salvage rates also achieved in
the indirect revascularization group (Fig. 4). This means that
achieving pulsatile arterial ﬂow straight to the site of
ischemic wound and gangrene is of critical importance to
effectively treat wound infection, to accelerate the healing
process and to avoid limb loss.Figure 4. Forest plot for effectiveness of direct revascularization versu
limb salvage in patients with ischemic tissue lesions of the foot.Although the efﬁcacy of angiosome-targeted revascular-
ization seems straightforward, a number of recent studies
indicated its limited value.7e10 However, the results of these
studies might be affected by their small size,6,7 by failing to
consider censoring9,10 or to adequately compare or report
on the outcome after these two revascularization strate-
gies.8,9 Indeed, this meta-analysis showed a limited het-
erogeneity of the included studies and all of these showed a
trend toward better wound healing and limb salvage rates.
Pooled limb salvage rates indicate a marked advantage for
direct revascularization over indirect revascularization in
these high-risk patients (Fig. 4).
A number of limitations possibly affecting these results
should be acknowledged. Seven out of nine studies were
retrospective and this might introduce a signiﬁcant bias,
particularly in the assessment of the nature and severity of
ischemic tissue lesions. Furthermore, patients included in the
indirect revascularization group were possibly historical
controls. The lack of comparability of the study groups was
not properly addressed in these studies. In fact, only three
studies adjusted for possible differences between the study
groups by propensity score matching, but failed to report on
all the main outcome end-points, thus preventing a through
pooled analysis of their results. Furthermore, there are not
enough data available to assess the comparability of the site,
severity, duration, and methods of local treatment of these
tissue lesions. In fact, only two large studies13,15 stratiﬁed the
severity of foot wound by using different wound classiﬁcation
systems and found a similar prevalence of severe wounds in
the study groups. The lack of data on angiographic status of
the foot arteries should be seen also as amajor limiting factor
in the analysis of these data. These studies predominantly
included patients with diabetes and there is a lack of data ons indirect revascularization according to the angiosome concept in
Figure 5. Funnel plot for effectiveness of direct revascularization
versus indirect revascularization according to the angiosome
concept in limb salvage in patients with ischemic tissue lesions of
the foot.
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diabetic patients. Therefore, it is unclear whether this strat-
egy is also effective in non-diabetic patients. In a recent
systematic review,19 some of these limitations were recog-
nized as important. Indeed, these may prevent conclusive
results on the validity of the angiosome concept.
Besides possible methodological issues affecting the re-
sults of the studies included here, there are also otherFigure 6. Pooled survival after direct and indirect revascularization acc
estimation of 1-year limb salvage and ﬁve studies for 2-year limb salvtechnical issues which cannot be addressed in this meta-
analysis. In fact, there is a lack of data on the feasibility
of direct, angiosome-targeted revascularization in those
patients who otherwise underwent indirect revasculariza-
tion of the ischemic tissue lesions. This prevents any anal-
ysis of the outcome of those legs in which direct
revascularization was not feasible and/or had possibly more
diffuse atherosclerosis of the crural and foot arteries. In
fact, the well established prognostic impact of the angio-
graphic runoff status20 might have inﬂuenced the results of
this analysis. This explains why a few studies evaluating the
impact of severity of atherosclerosis and of the status of the
pedal arch and collateral circulation of the foot did not
conﬁrm the value of angiosome-targeted revasculariza-
tion.6,9 Beside these potential pitfalls, the results of this
meta-analysis suggest that, when technically feasible, any
revascularization attempt should be accomplished accord-
ing to the angiosome principle as it seems superior to any
indirect revascularization strategy. Future research should
assess the feasibility of angiosome-targeted revasculariza-
tion of the foot as well as the clinical and therapeutic im-
plications in those patients in which direct revascularization
is not feasible.
In conclusion, the results of the present meta-analysis
suggest that, when feasible, direct revascularization of the
foot angiosome affected by ischemic tissue lesions isording to the angiosome concept. Six studies were considered for
age (estimated HR 0.55, 95% CI: 0.40e0.76).
522 F. Biancari and T. Juvonenassociated with signiﬁcantly higher rates of wound healing
and limb salvage compared with indirect revascularization.
Further studies of better quality, reporting on the angio-
graphic status of the foot arteries, the characteristics of the
wounds, all major outcome end-points, and adjusted anal-
ysis for differences between the study groups are needed to
conﬁrm the present ﬁndings.
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